MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    History of Comorbidities and their Association with Developing Cognitive Dysfunction in PD

    C. Venuto, K. Kieburtz, K. Herbst, G. Smith (Rochester, USA)

    Objective: To examine comorbidities associated with incident cognitive dysfunction in PD. Background: The risk of dementia is up to six-times higher in PD compared to…
  • 2022 International Congress

    RETINAL THICKNESS IN ESSENTIAL TREMOR AND EARLY PARKINSON’S DISEASE: EXPLORING DIAGNOSTIC INSIGHTS

    C. Terravecchia, G. Mostile, CG. Chisari, A. Luca, R. Terranova, C. Rascunà, G. Donzuso, CE. Cicero, G. Sciacca, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To explore the possible role of retinal assessment in a differential diagnostic setting in Essential Tremor (ET) through a standardized OCT protocol. Background: ET…
  • 2022 International Congress

    Use of bupivacaine in the evaluation of acute secondary cervical dystonia (CD)

    JR. Chai, S. Bansal, C. Li, M. Jog (London, Canada)

    Objective: To highlight the potential use of bupivacaine/analgesics in assessing cervical dystonia, where disabling local pain can be a confounder and limits clinical examination. Background:…
  • 2022 International Congress

    Antidyskinetic Effects of CaV1.3 Calcium Channel Gene Silencing in Aged Male and Female Parkinsonian Macaques

    K. Steece-Collier, F. Manfredsson, S. Muller, M. Caulfield, M. Vander Werp, J. Stancati, Y. Chu, I. Sandoval, T. Collier, J. Kordower (Grand Rapids, USA)

    Objective: To determine whether striatal CaV1.3 gene silencing ameliorates levodopa-induced dyskinesias (LID) in the preclinical gold-standard non-human primate (NHP) model without altering levodopa’s antiparkinsonian benefit.…
  • 2022 International Congress

    Gerstmann-Straussler-Scheinker Syndrome Manifesting Levodopa-Responsive Parkinsonism, Levodopa-Induced Dyskinesia, and Abnormal DaT-SPECT

    S. Aradi (Tampa, USA)

    Objective: The objective of this report is to describe previously unreported features in a patient with Gerstmann-Straussler-Scheinker syndrome (GSS) due to the F198S mutation. Background:…
  • 2022 International Congress

    Throat Clearing tics In Wilson’s Disease- An Unusual Manifestation

    V H. Ganaraja, A. Konnur, S. Kodapala (BENGALURU, India)

    Objective: To report unusual presentation of throat clearing tics in a 15 year old Indian girl with Wilson’s disease (WD). Background: WD is one of…
  • 2022 International Congress

    Prevalence, clinical and neuropsychiatric aspects of Sleep Disorders in Parkinson’s disease: a meta-analysis

    G. Maggi, F. Cerciello, I. Obeso, G. Santangelo (Caserta, Italy)

    Objective: The present meta-analysis aims to provide a reliable estimate of the prevalence and associated clinical and neuropsychiatric aspects of the most frequent sleep disorders…
  • 2022 International Congress

    Association of creaky voice with motor severity in Parkinson’s disease using an automated algorithm.

    V. Wei, C. Manxhari, E. Morrison, K. Smith (Worcester, USA)

    Objective: We characterized creaky voice in Parkinson’s disease (PD) and evaluated the association of this acoustic phenomenon with motor and cognitive status. Background: Creaky voice (“vocal fry”)…
  • 2022 International Congress

    The development of a screening tool to identify movement disorders in patients with inborn errors of metabolism

    L. Koens, M. Klamer, D. Sival, B. Balint, K. Bhatia, M. Contarino, M. van Egmond, R. Erro, J. Friedman, V. Fung, C. Ganos, M. Kurian, A. Lang, E. Mcgovern, E. Roze, T. de Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To develop a user-friendly rapid screening tool for non-movement disorder specialists to detect movement disorders in patients with inborn errors of metabolism. Background: Movement…
  • 2022 International Congress

    Psychiatric evaluation according to Brief Psychiatric Rating Scale-Expanded in patients with Parkinson’s disease

    N. Ben Ali, M. Ben Mahmoud, E. Derbel, H. Jamoussi, S. Fray, M. Fredj (Tunis, Tunisia)

    Objective: The aim of the study was to evaluate psychiatric manifestations of Parkinson’s disease (PD) and to establish statistical links with sociodemographic and clinical PD…
  • « Previous Page
  • 1
  • …
  • 755
  • 756
  • 757
  • 758
  • 759
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley